Advanced Biomed Inc.
ADVB· Nasdaq
ADVBAdvanced Biomed Inc.
Filed Nov 19, 2025 · 10-Q · 50 days after period end · 0001213900-25-112602
| Metric | Q1 2026 | Q1 2025 |
|---|---|---|
| Net Income | -$386.90K | -$265.58K |
| EPS Diluted | -$0.02 | -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Advanced Biomed Inc. · CIK 1941029 · Engraved from SEC EDGAR
ended Sep 30, 2025 · filed Nov 19, 2025 · 50 d after period end
